Speaker illustration

Doctor Kuniaki Takahashi

Kindai University Hospital, Osaka (Japan)

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: insights from the Global Leaders trial

Event: ESC Congress 2019

Topic: Adjunctive Pharmacotherapy

Session: Percutaneous coronary syndrome: pharma and devices

Thumbnail

Ischemic efficacy and bleeding safety of ticagrelor monotherapy in patients with multivessel percutaneous coronary intervention: insights from the Global Leaders trial

Event: ESC Congress 2019

Topic: Adjunctive Pharmacotherapy

Session: Percutaneous coronary syndrome: pharma and devices

Thumbnail

Efficacy and safety of ticagrelor monotherapy in patients with complex percutaneous coronary intervention: insights from the Global Leaders trial

Event: ESC Congress 2019

Topic: Adjunctive Pharmacotherapy

Session: Percutaneous coronary syndrome: pharma and devices

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb